Global Hospital-acquired Infection Diagnostics Market Growth (Status and Outlook) 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Hospital-acquired Infection Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Hospital-acquired Infection Diagnostics market size is USD million in 2022 from USD 4745.4 million in 2021, with a change of % between 2021 and 2022. The global Hospital-acquired Infection Diagnostics market size will reach USD 7306.2 million in 2028, growing at a CAGR of 6.4% over the analysis period.
The United States Hospital-acquired Infection Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-acquired Infection Diagnostics market, reaching US$ million by the year 2028. As for the Europe Hospital-acquired Infection Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-acquired Infection Diagnostics players cover Abbott Laboratories, Advan DX, Abbott, and Astrazeneca PLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-acquired Infection Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
As the global economy mends, the 2021 growth of Hospital-acquired Infection Diagnostics will have significant change from previous year. According to our (LP Information) latest study, the global Hospital-acquired Infection Diagnostics market size is USD million in 2022 from USD 4745.4 million in 2021, with a change of % between 2021 and 2022. The global Hospital-acquired Infection Diagnostics market size will reach USD 7306.2 million in 2028, growing at a CAGR of 6.4% over the analysis period.
The United States Hospital-acquired Infection Diagnostics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hospital-acquired Infection Diagnostics market, reaching US$ million by the year 2028. As for the Europe Hospital-acquired Infection Diagnostics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hospital-acquired Infection Diagnostics players cover Abbott Laboratories, Advan DX, Abbott, and Astrazeneca PLC, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hospital-acquired Infection Diagnostics market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Instrument and Reagents
- Consumables
- Hospital
- Clinics
- Ambulatory Surgery Centers (ASC)
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abbott Laboratories
- Advan DX
- Abbott
- Astrazeneca PLC
- Bayer Schering Pharma LLC
- Becton Dickinson And Company
- Cepheid Inc.
- Roche AG
- Daiichi Sankyo
- Hologic, Inc.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size 2017-2028
2.1.2 Hospital-acquired Infection Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hospital-acquired Infection Diagnostics Segment by Type
2.2.1 Instrument and Reagents
2.2.2 Consumables
2.3 Hospital-acquired Infection Diagnostics Market Size by Type
2.3.1 Hospital-acquired Infection Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Hospital-acquired Infection Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Ambulatory Surgery Centers (ASC)
2.4.4 Others
2.5 Hospital-acquired Infection Diagnostics Market Size by Application
2.5.1 Hospital-acquired Infection Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Hospital-acquired Infection Diagnostics Market Size Market Share by Players
3.1.1 Global Hospital-acquired Infection Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Hospital-acquired Infection Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS BY REGIONS
4.1 Hospital-acquired Infection Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.3 APAC Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.4 Europe Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
5.2 Americas Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
5.3 Americas Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022)
6.2 APAC Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
6.3 APAC Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-acquired Infection Diagnostics by Country (2017-2022)
7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-acquired Infection Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST
10.1 Global Hospital-acquired Infection Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Hospital-acquired Infection Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Hospital-acquired Infection Diagnostics Forecast
10.1.3 APAC Hospital-acquired Infection Diagnostics Forecast
10.1.4 Europe Hospital-acquired Infection Diagnostics Forecast
10.1.5 Middle East & Africa Hospital-acquired Infection Diagnostics Forecast
10.2 Americas Hospital-acquired Infection Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Hospital-acquired Infection Diagnostics Market Forecast
10.2.2 Canada Hospital-acquired Infection Diagnostics Market Forecast
10.2.3 Mexico Hospital-acquired Infection Diagnostics Market Forecast
10.2.4 Brazil Hospital-acquired Infection Diagnostics Market Forecast
10.3 APAC Hospital-acquired Infection Diagnostics Forecast by Region (2023-2028)
10.3.1 China Hospital-acquired Infection Diagnostics Market Forecast
10.3.2 Japan Hospital-acquired Infection Diagnostics Market Forecast
10.3.3 Korea Hospital-acquired Infection Diagnostics Market Forecast
10.3.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Forecast
10.3.5 India Hospital-acquired Infection Diagnostics Market Forecast
10.3.6 Australia Hospital-acquired Infection Diagnostics Market Forecast
10.4 Europe Hospital-acquired Infection Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Hospital-acquired Infection Diagnostics Market Forecast
10.4.2 France Hospital-acquired Infection Diagnostics Market Forecast
10.4.3 UK Hospital-acquired Infection Diagnostics Market Forecast
10.4.4 Italy Hospital-acquired Infection Diagnostics Market Forecast
10.4.5 Russia Hospital-acquired Infection Diagnostics Market Forecast
10.5 Middle East & Africa Hospital-acquired Infection Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Hospital-acquired Infection Diagnostics Market Forecast
10.5.2 South Africa Hospital-acquired Infection Diagnostics Market Forecast
10.5.3 Israel Hospital-acquired Infection Diagnostics Market Forecast
10.5.4 Turkey Hospital-acquired Infection Diagnostics Market Forecast
10.5.5 GCC Countries Hospital-acquired Infection Diagnostics Market Forecast
10.6 Global Hospital-acquired Infection Diagnostics Forecast by Type (2023-2028)
10.7 Global Hospital-acquired Infection Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offered
11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Advan DX
11.2.1 Advan DX Company Information
11.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Offered
11.2.3 Advan DX Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Advan DX Main Business Overview
11.2.5 Advan DX Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Hospital-acquired Infection Diagnostics Product Offered
11.3.3 Abbott Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Astrazeneca PLC
11.4.1 Astrazeneca PLC Company Information
11.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offered
11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astrazeneca PLC Main Business Overview
11.4.5 Astrazeneca PLC Latest Developments
11.5 Bayer Schering Pharma LLC
11.5.1 Bayer Schering Pharma LLC Company Information
11.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offered
11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Schering Pharma LLC Main Business Overview
11.5.5 Bayer Schering Pharma LLC Latest Developments
11.6 Becton Dickinson And Company
11.6.1 Becton Dickinson And Company Company Information
11.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offered
11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Becton Dickinson And Company Main Business Overview
11.6.5 Becton Dickinson And Company Latest Developments
11.7 Cepheid Inc.
11.7.1 Cepheid Inc. Company Information
11.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offered
11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Cepheid Inc. Main Business Overview
11.7.5 Cepheid Inc. Latest Developments
11.8 Roche AG
11.8.1 Roche AG Company Information
11.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Offered
11.8.3 Roche AG Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche AG Main Business Overview
11.8.5 Roche AG Latest Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Information
11.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offered
11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Daiichi Sankyo Main Business Overview
11.9.5 Daiichi Sankyo Latest Developments
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Information
11.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offered
11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Hologic, Inc. Main Business Overview
11.10.5 Hologic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Hospital-acquired Infection Diagnostics Market Size 2017-2028
2.1.2 Hospital-acquired Infection Diagnostics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hospital-acquired Infection Diagnostics Segment by Type
2.2.1 Instrument and Reagents
2.2.2 Consumables
2.3 Hospital-acquired Infection Diagnostics Market Size by Type
2.3.1 Hospital-acquired Infection Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
2.4 Hospital-acquired Infection Diagnostics Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Ambulatory Surgery Centers (ASC)
2.4.4 Others
2.5 Hospital-acquired Infection Diagnostics Market Size by Application
2.5.1 Hospital-acquired Infection Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
3 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET SIZE BY PLAYER
3.1 Hospital-acquired Infection Diagnostics Market Size Market Share by Players
3.1.1 Global Hospital-acquired Infection Diagnostics Revenue by Players (2020-2022)
3.1.2 Global Hospital-acquired Infection Diagnostics Revenue Market Share by Players (2020-2022)
3.2 Global Hospital-acquired Infection Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS BY REGIONS
4.1 Hospital-acquired Infection Diagnostics Market Size by Regions (2017-2022)
4.2 Americas Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.3 APAC Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.4 Europe Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
4.5 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Growth (2017-2022)
5 AMERICAS
5.1 Americas Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022)
5.2 Americas Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
5.3 Americas Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022)
6.2 APAC Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
6.3 APAC Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Hospital-acquired Infection Diagnostics by Country (2017-2022)
7.2 Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
7.3 Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Hospital-acquired Infection Diagnostics by Region (2017-2022)
8.2 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022)
8.3 Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL HOSPITAL-ACQUIRED INFECTION DIAGNOSTICS MARKET FORECAST
10.1 Global Hospital-acquired Infection Diagnostics Forecast by Regions (2023-2028)
10.1.1 Global Hospital-acquired Infection Diagnostics Forecast by Regions (2023-2028)
10.1.2 Americas Hospital-acquired Infection Diagnostics Forecast
10.1.3 APAC Hospital-acquired Infection Diagnostics Forecast
10.1.4 Europe Hospital-acquired Infection Diagnostics Forecast
10.1.5 Middle East & Africa Hospital-acquired Infection Diagnostics Forecast
10.2 Americas Hospital-acquired Infection Diagnostics Forecast by Country (2023-2028)
10.2.1 United States Hospital-acquired Infection Diagnostics Market Forecast
10.2.2 Canada Hospital-acquired Infection Diagnostics Market Forecast
10.2.3 Mexico Hospital-acquired Infection Diagnostics Market Forecast
10.2.4 Brazil Hospital-acquired Infection Diagnostics Market Forecast
10.3 APAC Hospital-acquired Infection Diagnostics Forecast by Region (2023-2028)
10.3.1 China Hospital-acquired Infection Diagnostics Market Forecast
10.3.2 Japan Hospital-acquired Infection Diagnostics Market Forecast
10.3.3 Korea Hospital-acquired Infection Diagnostics Market Forecast
10.3.4 Southeast Asia Hospital-acquired Infection Diagnostics Market Forecast
10.3.5 India Hospital-acquired Infection Diagnostics Market Forecast
10.3.6 Australia Hospital-acquired Infection Diagnostics Market Forecast
10.4 Europe Hospital-acquired Infection Diagnostics Forecast by Country (2023-2028)
10.4.1 Germany Hospital-acquired Infection Diagnostics Market Forecast
10.4.2 France Hospital-acquired Infection Diagnostics Market Forecast
10.4.3 UK Hospital-acquired Infection Diagnostics Market Forecast
10.4.4 Italy Hospital-acquired Infection Diagnostics Market Forecast
10.4.5 Russia Hospital-acquired Infection Diagnostics Market Forecast
10.5 Middle East & Africa Hospital-acquired Infection Diagnostics Forecast by Region (2023-2028)
10.5.1 Egypt Hospital-acquired Infection Diagnostics Market Forecast
10.5.2 South Africa Hospital-acquired Infection Diagnostics Market Forecast
10.5.3 Israel Hospital-acquired Infection Diagnostics Market Forecast
10.5.4 Turkey Hospital-acquired Infection Diagnostics Market Forecast
10.5.5 GCC Countries Hospital-acquired Infection Diagnostics Market Forecast
10.6 Global Hospital-acquired Infection Diagnostics Forecast by Type (2023-2028)
10.7 Global Hospital-acquired Infection Diagnostics Forecast by Application (2023-2028)
11 KEY PLAYERS ANALYSIS
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offered
11.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Advan DX
11.2.1 Advan DX Company Information
11.2.2 Advan DX Hospital-acquired Infection Diagnostics Product Offered
11.2.3 Advan DX Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Advan DX Main Business Overview
11.2.5 Advan DX Latest Developments
11.3 Abbott
11.3.1 Abbott Company Information
11.3.2 Abbott Hospital-acquired Infection Diagnostics Product Offered
11.3.3 Abbott Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Abbott Main Business Overview
11.3.5 Abbott Latest Developments
11.4 Astrazeneca PLC
11.4.1 Astrazeneca PLC Company Information
11.4.2 Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offered
11.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Astrazeneca PLC Main Business Overview
11.4.5 Astrazeneca PLC Latest Developments
11.5 Bayer Schering Pharma LLC
11.5.1 Bayer Schering Pharma LLC Company Information
11.5.2 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offered
11.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Bayer Schering Pharma LLC Main Business Overview
11.5.5 Bayer Schering Pharma LLC Latest Developments
11.6 Becton Dickinson And Company
11.6.1 Becton Dickinson And Company Company Information
11.6.2 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offered
11.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Becton Dickinson And Company Main Business Overview
11.6.5 Becton Dickinson And Company Latest Developments
11.7 Cepheid Inc.
11.7.1 Cepheid Inc. Company Information
11.7.2 Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offered
11.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Cepheid Inc. Main Business Overview
11.7.5 Cepheid Inc. Latest Developments
11.8 Roche AG
11.8.1 Roche AG Company Information
11.8.2 Roche AG Hospital-acquired Infection Diagnostics Product Offered
11.8.3 Roche AG Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Roche AG Main Business Overview
11.8.5 Roche AG Latest Developments
11.9 Daiichi Sankyo
11.9.1 Daiichi Sankyo Company Information
11.9.2 Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offered
11.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Daiichi Sankyo Main Business Overview
11.9.5 Daiichi Sankyo Latest Developments
11.10 Hologic, Inc.
11.10.1 Hologic, Inc. Company Information
11.10.2 Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offered
11.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Hologic, Inc. Main Business Overview
11.10.5 Hologic, Inc. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Hospital-acquired Infection Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instrument and Reagents
Table 3. Major Players of Consumables
Table 4. Hospital-acquired Infection Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Hospital-acquired Infection Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Hospital-acquired Infection Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Hospital-acquired Infection Diagnostics Key Players Head office and Products Offered
Table 13. Hospital-acquired Infection Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hospital-acquired Infection Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Hospital-acquired Infection Diagnostics
Table 43. Key Market Challenges & Risks of Hospital-acquired Infection Diagnostics
Table 44. Key Industry Trends of Hospital-acquired Infection Diagnostics
Table 45. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Laboratories Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 52. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offered
Table 53. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Advan DX Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 57. Advan DX Hospital-acquired Infection Diagnostics Product Offered
Table 58. Advan DX Main Business
Table 59. Advan DX Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Advan DX Latest Developments
Table 61. Abbott Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 62. Abbott Hospital-acquired Infection Diagnostics Product Offered
Table 63. Abbott Main Business
Table 64. Abbott Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Abbott Latest Developments
Table 66. Astrazeneca PLC Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 67. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offered
Table 68. Astrazeneca PLC Main Business
Table 69. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Astrazeneca PLC Latest Developments
Table 71. Bayer Schering Pharma LLC Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 72. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offered
Table 73. Bayer Schering Pharma LLC Main Business
Table 74. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Bayer Schering Pharma LLC Latest Developments
Table 76. Becton Dickinson And Company Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 77. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offered
Table 78. Becton Dickinson And Company Main Business
Table 79. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Becton Dickinson And Company Latest Developments
Table 81. Cepheid Inc. Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 82. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offered
Table 83. Cepheid Inc. Main Business
Table 84. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Cepheid Inc. Latest Developments
Table 86. Roche AG Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 87. Roche AG Hospital-acquired Infection Diagnostics Product Offered
Table 88. Roche AG Main Business
Table 89. Roche AG Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche AG Latest Developments
Table 91. Daiichi Sankyo Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 92. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offered
Table 93. Daiichi Sankyo Main Business
Table 94. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Daiichi Sankyo Latest Developments
Table 96. Hologic, Inc. Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 97. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offered
Table 98. Hologic, Inc. Main Business
Table 99. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Hologic, Inc. Latest Developments
Table 1. Hospital-acquired Infection Diagnostics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Instrument and Reagents
Table 3. Major Players of Consumables
Table 4. Hospital-acquired Infection Diagnostics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 7. Hospital-acquired Infection Diagnostics Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 10. Global Hospital-acquired Infection Diagnostics Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Player (2020-2022)
Table 12. Hospital-acquired Infection Diagnostics Key Players Head office and Products Offered
Table 13. Hospital-acquired Infection Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Hospital-acquired Infection Diagnostics Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Regions (2017-2022)
Table 18. Americas Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Country (2017-2022)
Table 20. Americas Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 22. Americas Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 24. APAC Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Region (2017-2022)
Table 26. APAC Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 28. APAC Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 30. Europe Hospital-acquired Infection Diagnostics Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Country (2017-2022)
Table 32. Europe Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 34. Europe Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Hospital-acquired Infection Diagnostics
Table 43. Key Market Challenges & Risks of Hospital-acquired Infection Diagnostics
Table 44. Key Industry Trends of Hospital-acquired Infection Diagnostics
Table 45. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Hospital-acquired Infection Diagnostics Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Hospital-acquired Infection Diagnostics Market Size Market Share Forecast by Application (2023-2028)
Table 51. Abbott Laboratories Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 52. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offered
Table 53. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Abbott Laboratories Main Business
Table 55. Abbott Laboratories Latest Developments
Table 56. Advan DX Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 57. Advan DX Hospital-acquired Infection Diagnostics Product Offered
Table 58. Advan DX Main Business
Table 59. Advan DX Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Advan DX Latest Developments
Table 61. Abbott Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 62. Abbott Hospital-acquired Infection Diagnostics Product Offered
Table 63. Abbott Main Business
Table 64. Abbott Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Abbott Latest Developments
Table 66. Astrazeneca PLC Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 67. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offered
Table 68. Astrazeneca PLC Main Business
Table 69. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Astrazeneca PLC Latest Developments
Table 71. Bayer Schering Pharma LLC Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 72. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offered
Table 73. Bayer Schering Pharma LLC Main Business
Table 74. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Bayer Schering Pharma LLC Latest Developments
Table 76. Becton Dickinson And Company Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 77. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offered
Table 78. Becton Dickinson And Company Main Business
Table 79. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Becton Dickinson And Company Latest Developments
Table 81. Cepheid Inc. Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 82. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offered
Table 83. Cepheid Inc. Main Business
Table 84. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Cepheid Inc. Latest Developments
Table 86. Roche AG Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 87. Roche AG Hospital-acquired Infection Diagnostics Product Offered
Table 88. Roche AG Main Business
Table 89. Roche AG Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Roche AG Latest Developments
Table 91. Daiichi Sankyo Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 92. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offered
Table 93. Daiichi Sankyo Main Business
Table 94. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Daiichi Sankyo Latest Developments
Table 96. Hologic, Inc. Details, Company Type, Hospital-acquired Infection Diagnostics Area Served and Its Competitors
Table 97. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offered
Table 98. Hologic, Inc. Main Business
Table 99. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Hologic, Inc. Latest Developments
LIST OF FIGURES
Figure 1. Hospital-acquired Infection Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 7. Hospital-acquired Infection Diagnostics in Hospital
Figure 8. Global Hospital-acquired Infection Diagnostics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Hospital-acquired Infection Diagnostics in Clinics
Figure 10. Global Hospital-acquired Infection Diagnostics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Hospital-acquired Infection Diagnostics in Ambulatory Surgery Centers (ASC)
Figure 12. Global Hospital-acquired Infection Diagnostics Market: Ambulatory Surgery Centers (ASC) (2017-2022) & ($ Millions)
Figure 13. Hospital-acquired Infection Diagnostics in Others
Figure 14. Global Hospital-acquired Infection Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 16. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Player in 2021
Figure 17. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Hospital-acquired Infection Diagnostics Value Market Share by Country in 2021
Figure 23. Americas Hospital-acquired Infection Diagnostics Consumption Market Share by Type in 2021
Figure 24. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 25. United States Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Region in 2021
Figure 30. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 31. China Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Country in 2021
Figure 38. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 39. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 40. Germany Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 48. Egypt Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. United States Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. China Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. India Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. France Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. UK Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 1. Hospital-acquired Infection Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 7. Hospital-acquired Infection Diagnostics in Hospital
Figure 8. Global Hospital-acquired Infection Diagnostics Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Hospital-acquired Infection Diagnostics in Clinics
Figure 10. Global Hospital-acquired Infection Diagnostics Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Hospital-acquired Infection Diagnostics in Ambulatory Surgery Centers (ASC)
Figure 12. Global Hospital-acquired Infection Diagnostics Market: Ambulatory Surgery Centers (ASC) (2017-2022) & ($ Millions)
Figure 13. Hospital-acquired Infection Diagnostics in Others
Figure 14. Global Hospital-acquired Infection Diagnostics Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 16. Global Hospital-acquired Infection Diagnostics Revenue Market Share by Player in 2021
Figure 17. Global Hospital-acquired Infection Diagnostics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Hospital-acquired Infection Diagnostics Value Market Share by Country in 2021
Figure 23. Americas Hospital-acquired Infection Diagnostics Consumption Market Share by Type in 2021
Figure 24. Americas Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 25. United States Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Region in 2021
Figure 30. APAC Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 31. China Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Country in 2021
Figure 38. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 39. Europe Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 40. Germany Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size Market Share by Application in 2021
Figure 48. Egypt Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Hospital-acquired Infection Diagnostics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 57. United States Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 61. China Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 65. India Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 68. France Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 69. UK Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Hospital-acquired Infection Diagnostics Market Size 2023-2028 ($ Millions)
